Dysregulation of apoptosis genes in hematopoietic malignancies, Oncogene, vol.21, issue.21, pp.3459-3474, 2002. ,
DOI : 10.1200/JCO.1999.17.9.2941
Chronic Lymphocytic Leukemia, New England Journal of Medicine, vol.352, issue.8, pp.804-815, 2005. ,
DOI : 10.1056/NEJMra041720
URL : https://hal.archives-ouvertes.fr/hal-01375537
G-protein-coupled receptors and cancer, Nature Reviews Cancer, vol.341, issue.2, pp.79-94, 2007. ,
DOI : 10.4049/jimmunol.172.5.2853
The 100-kDa Neurotensin Receptor Is gp95/Sortilin, A Non-G-Protein-coupled Receptor, Journal of Biological Chemistry, vol.63, issue.41, pp.26273-26276, 1998. ,
DOI : 10.1074/jbc.273.6.3582
URL : http://www.jbc.org/content/273/41/26273.full.pdf
Neurotensin counteracts apoptosis in breast cancer cells, Biochemical and Biophysical Research Communications, vol.295, issue.2, pp.482-488, 2002. ,
DOI : 10.1016/S0006-291X(02)00703-9
Neurotensin (NTS) and its receptor (NTSR1) causes EGFR, HER2 and HER3 over-expression and their autocrine/paracrine activation in lung tumors, confirming responsiveness to erlotinib, Oncotarget, vol.5, issue.18, pp.8252-8269, 2014. ,
DOI : 10.18632/oncotarget.1633
URL : http://www.impactjournals.com/oncotarget/index.php?journal=oncotarget&page=article&op=download&path%5B%5D=1633&path%5B%5D=4619
The potential use of the neurotensin high affinity receptor 1 as a biomarker for cancer progression and as a component of personalized medicine in selective cancers, Biochimie, vol.93, issue.9, pp.1369-1378, 2011. ,
DOI : 10.1016/j.biochi.2011.04.024
Differential Expression of Neurotensin and Specific Receptors, NTSR1 and NTSR2, in Normal and Malignant Human B Lymphocytes, The Journal of Immunology, vol.189, issue.11, pp.5293-5303, 2012. ,
DOI : 10.4049/jimmunol.1102937
URL : https://hal.archives-ouvertes.fr/hal-00872646
The COSMIC (Catalogue of Somatic Mutations in Cancer) database and website, British Journal of Cancer, vol.32, issue.2, pp.355-358, 2004. ,
DOI : 10.1093/nar/gkh073
Induction of cell death by endogenous nerve growth factor through its p75 receptor, Nature, vol.383, issue.6596, pp.166-168, 1996. ,
DOI : 10.1038/383166a0
Activation of EGFR, HER2 and HER3 by neurotensin/neurotensin receptor 1 renders breast tumors aggressive yet highly responsive to lapatinib and metformin in mice, Oncotarget, vol.5, issue.18, pp.8235-8251, 2014. ,
DOI : 10.18632/oncotarget.1632
URL : http://www.impactjournals.com/oncotarget/index.php?journal=oncotarget&page=article&op=download&path%5B%5D=1632&path%5B%5D=3046
Sortilin mediates the release and transfer of exosomes in concert with two tyrosine kinase receptors, Journal of Cell Science, vol.127, issue.18, pp.3983-3997, 2014. ,
DOI : 10.1242/jcs.149336
URL : https://hal.archives-ouvertes.fr/hal-01059696
The Implications of Sortilin/Vps10p Domain Receptors in Neurological and Human Diseases, CNS & Neurological Disorders - Drug Targets, vol.13, issue.8, pp.1354-1365, 2014. ,
DOI : 10.2174/1871527313666141023151642
Gefitinib targets ZAP-70-expressing chronic lymphocytic leukemia cells and inhibits B-cell receptor signaling, Cell Death & Disease, vol.9, issue.10, p.1439, 2014. ,
DOI : 10.1038/sj.mt.6300184
URL : http://www.nature.com/cddis/journal/v5/n10/pdf/cddis2014391a.pdf
Role of Endogenous Brain-Derived Neurotrophic Factor and Sortilin in B Cell Survival, The Journal of Immunology, vol.181, issue.5, pp.3027-3038, 2008. ,
DOI : 10.4049/jimmunol.181.5.3027
URL : https://hal.archives-ouvertes.fr/hal-00453223
On Trk--The TrkB Signal Transduction Pathway Is an Increasingly Important Target in Cancer Biology, Clinical Cancer Research, vol.15, issue.19, pp.5962-5967, 2009. ,
DOI : 10.1158/1078-0432.CCR-08-0651
URL : http://clincancerres.aacrjournals.org/content/clincanres/15/19/5962.full.pdf
A neurotrophin axis in myeloma: TrkB and BDNF promote tumor-cell survival, Blood, vol.105, issue.11, pp.4429-4436, 2005. ,
DOI : 10.1182/blood-2004-08-3096
URL : http://www.bloodjournal.org/content/bloodjournal/105/11/4429.full.pdf
Gene silencing of the BDNF/TrkB axis in multiple myeloma blocks bone destruction and tumor burden in vitro and in vivo, International Journal of Cancer, vol.96, issue.5, pp.1074-1084, 2013. ,
DOI : 10.1182/blood-2003-06-1992
Recycling ability of the mouse and the human neurotensin type 2 receptors depends on a single tyrosine residue, J Cell Sci, vol.115, pp.165-173, 2002. ,
???Reversed-Phase High-Performance Liquid Chromatography Phosphochip Coupled to a Quadrupole Time-of-Flight Mass Spectrometer, Analytical Chemistry, vol.82, issue.3, pp.824-832, 2010. ,
DOI : 10.1021/ac901764g
Expression of apoptosis-regulating proteins in chronic lymphocytic leukemia: correlations with In vitro and In vivo chemoresponses, Blood, vol.91, pp.3379-3389, 1998. ,
The Akt signaling pathway determines the different proliferative capacity of chronic lymphocytic leukemia B-cells from patients with progressive and stable disease, Leukemia, vol.72, issue.1, pp.110-120, 2007. ,
DOI : 10.1182/blood-2002-11-3569
The Akt/Mcl-1 pathway plays a prominent role in mediating antiapoptotic signals downstream of the B-cell receptor in chronic lymphocytic leukemia B cells, Blood, vol.111, issue.2, pp.846-855, 2008. ,
DOI : 10.1182/blood-2007-05-089037
The B-cell receptor signaling pathway as a therapeutic target in CLL, Blood, vol.120, issue.6, pp.1175-1184, 2012. ,
DOI : 10.1182/blood-2012-02-362624
Critical Signal Transduction Pathways in CLL, Adv Exp Med Biol, vol.792, pp.215-239, 2013. ,
DOI : 10.1007/978-1-4614-8051-8_10
URL : http://europepmc.org/articles/pmc3918736?pdf=render
Constitutively activated Notch signaling is involved in survival and apoptosis resistance of B-CLL cells, Blood, vol.113, issue.4, pp.856-865, 2009. ,
DOI : 10.1182/blood-2008-02-139725
URL : http://www.bloodjournal.org/content/bloodjournal/113/4/856.full.pdf
A Pathobiological Role of the Insulin Receptor in Chronic Lymphocytic Leukemia, Clinical Cancer Research, vol.17, issue.9, pp.2679-2692, 2011. ,
DOI : 10.1158/1078-0432.CCR-10-2058
Insulin-like growth factor-1 receptor (IGF1R) as a novel target in chronic lymphocytic leukemia, Blood, vol.122, issue.9, pp.1621-1633, 2013. ,
DOI : 10.1182/blood-2013-02-484386
URL : http://www.bloodjournal.org/content/bloodjournal/122/9/1621.full.pdf
Chronic lymphocytic leukemia B cells express functional CXCR4 chemokine receptors that mediate spontaneous migration beneath bone marrow stromal cells, Blood, vol.94, pp.3658-3667, 1999. ,
Overexpression of the chemokine receptor CXCR4 in B cell chronic lymphocytic leukemia is associated with increased functional response to stromal cell-derived factor-1 (SDF-1), Leukemia, vol.13, issue.12, pp.1954-1959, 1999. ,
DOI : 10.1038/sj.leu.2401602
Homeostatic chemokines increase survival of B-chronic lymphocytic leukemia cells through inactivation of transcription factor FOXO3a, Oncogene, vol.343, issue.50, pp.7081-7091, 2007. ,
DOI : 10.4049/jimmunol.167.6.3064
The role of chemokines in B cell chronic lymphocytic leukaemia: pathophysiological aspects and clinical impact, Annals of Hematology, vol.81, issue.5, pp.437-446, 2010. ,
DOI : 10.4049/jimmunol.179.7.4335
The G protein-coupled receptor CysLT1 mediates chemokine-like effects and prolongs survival in chronic lymphocytic leukemia, Leukemia & Lymphoma, vol.18, issue.4, pp.665-673, 2012. ,
DOI : 10.1111/j.1365-2141.2007.06590.x
Posttranslational Modification of Bcl-2 Facilitates Its Proteasome-Dependent Degradation: Molecular Characterization of the Involved Signaling Pathway, Molecular and Cellular Biology, vol.20, issue.5, pp.1886-1896, 2000. ,
DOI : 10.1128/MCB.20.5.1886-1896.2000
Antiapoptotic potency of Bcl-2 proteins primarily relies on their stability, not binding selectivity, Blood, vol.123, issue.18, pp.2806-2815, 2014. ,
DOI : 10.1182/blood-2013-08-519470
Methionine adenosyltransferase ?2 sumoylation positively regulate Bcl-2 expression in human colon and liver cancer cells, Oncotarget, vol.6, pp.37706-37723, 2015. ,
DOI : 10.18632/oncotarget.5342
URL : http://www.oncotarget.com/index.php?journal=oncotarget&page=article&op=download&path%5B%5D=5342&path%5B%5D=14881
Neurotensin regulation induces overexpression and activation of EGFR in HCC and restores response to erlotinib and sorafenib, Cancer Letters, vol.388, pp.73-84, 2017. ,
DOI : 10.1016/j.canlet.2016.11.032
Sezary Syndrome Cells Unlike Normal Circulating T Lymphocytes Fail to Migrate Following Engagement of NT1 Receptor, Journal of Investigative Dermatology, vol.122, issue.1, pp.111-118, 2004. ,
DOI : 10.1046/j.0022-202X.2003.22131.x
URL : https://doi.org/10.1046/j.0022-202x.2003.22131.x
Characterization of high affinity neurotensin receptor NTR1 in HL-60 cells and its down regulation during granulocytic differentiation, British Journal of Pharmacology, vol.46, issue.4, pp.1050-1056, 1999. ,
DOI : 10.1139/y89-247
Altered Expression of Neurotensin Receptors Is Associated with the Differentiation State of Prostate Cancer, Cancer Research, vol.70, issue.1, pp.347-356, 2010. ,
DOI : 10.1158/0008-5472.CAN-09-1252
Regression of Peyer's patches in Galphai2 deficient mice prior to colitis is associated with reduced expression of Bcl-2 and increased apoptosis, Gut, vol.51, issue.3, pp.392-397, 2002. ,
DOI : 10.1136/gut.51.3.392
B Cell Developmental Requirement for the G??i2 Gene, The Journal of Immunology, vol.170, issue.4, pp.1707-1715, 2003. ,
DOI : 10.4049/jimmunol.170.4.1707
URL : http://www.jimmunol.org/content/jimmunol/170/4/1707.full.pdf
Cell-Surface Receptors Transactivation Mediated by G Protein-Coupled Receptors, International Journal of Molecular Sciences, vol.47, issue.11, pp.19700-19728, 2014. ,
DOI : 10.1016/j.advenzreg.2006.12.011
Insulin-like Growth Factors Mediate Heterotrimeric G Protein-dependent ERK1/2 Activation by Transactivating Sphingosine 1-Phosphate Receptors, Journal of Biological Chemistry, vol.18, issue.42, pp.31399-31407, 2006. ,
DOI : 10.1523/JNEUROSCI.2730-05.2006
URL : http://www.jbc.org/content/281/42/31399.full.pdf
GPCR-jacking: from a new route in RTK signalling to a new concept in GPCR activation, Trends in Pharmacological Sciences, vol.28, issue.12, pp.602-607, 2007. ,
DOI : 10.1016/j.tips.2007.09.007
A role for chemokine receptor transactivation in growth factor signaling, EMBO reports, vol.163, issue.2, pp.151-156, 2001. ,
DOI : 10.1016/0167-0115(95)00159-X
URL : http://embor.embopress.org/content/embor/2/2/151.full.pdf
Role of the Sphingosine-1-Phosphate Receptor EDG-1 in PDGF-Induced Cell Motility, Science, vol.291, issue.5509, pp.1800-1803, 2001. ,
DOI : 10.1126/science.1057559
Nerve growth factor signaling involves interaction between the Trk A receptor and lysophosphatidate receptor 1 systems: nuclear translocation of the lysophosphatidate receptor 1 and Trk A receptors in pheochromocytoma 12 cells, Cellular Signalling, vol.16, issue.1, pp.127-136, 2004. ,
DOI : 10.1016/j.cellsig.2003.08.004
Protean agonism of the lysophosphatidic acid receptor-1 with Ki16425 reduces nerve growth factor-induced neurite outgrowth in pheochromocytoma 12 cells, Journal of Neurochemistry, vol.392, issue.6, pp.1920-1929, 2006. ,
DOI : 10.1016/S1388-1981(02)00330-X
Neurotensin is an antagonist of the human neurotensin NT2 receptor expressed in Chinese hamster ovary cells, European Journal of Pharmacology, vol.360, issue.2-3, pp.265-272, 1998. ,
DOI : 10.1016/S0014-2999(98)00678-5
Overexpression of the CXCR5 chemokine receptor, and its ligand, CXCL13 in B-cell chronic lymphocytic leukemia, Blood, vol.110, issue.9, pp.3316-3325, 2007. ,
DOI : 10.1182/blood-2007-05-089409
p75 neurotrophin receptor and pro-BDNF promote cell survival and migration in clear cell renal cell carcinoma, Oncotarget, vol.7, issue.23, pp.75-34480, 2016. ,
DOI : 10.18632/oncotarget.8911
Brain-derived neurotrophic factor is a potential osteoclast stimulating factor in multiple myeloma, Int J Cancer, vol.130, pp.827-836, 2012. ,
Identification of a low???molecular weight TrkB antagonist with anxiolytic and antidepressant activity in mice, Journal of Clinical Investigation, vol.121, issue.5, pp.1846-1857, 2011. ,
DOI : 10.1172/JCI43992DS1
Trypan Blue Exclusion Test of Cell Viability, Curr Protoc Immunol A3.B, vol.111, pp.1-3, 2015. ,
DOI : 10.1002/0471142735.ima03bs111